Gacang, Kate .
HRN: 28-36-89 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2026
CEFUROXIME 750MG (VIAL)
01/06/2026
01/12/2026
IV
750mg
Q8
UTI
Waiting Final Action
01/07/2026
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
01/07/2026
01/10/2026
ORAL
5ml
BID
Intestinal Parasitic Infection
Checking Final Appropriateness